Study Selection

KS Katelyn Sushko
QW Qi Rui Wang
HM Holly Tschirhart Menezes
DF Donna Fitzpatrick-Lewis
DS Diana Sherifali
ask Ask a question
Favorite

Following database searches, duplicates will be removed in EndNote and the remaining studies will be transferred to DistillerSR for the title and abstract screening and full-text review. Studies eligible for inclusion are primary studies that report benefits and limitations of mHealth technology used to support or facilitate virtual care for pregnant patients with gestational or pre-existing diabetes. Title and abstract screening will determine whether the study is about mHealth technology in pregnant women with gestational or pre-existing diabetes. The full-text review will determine whether the study elicits patient-reported benefits and/or limitations of mHealth technology. Title and abstract screening and full-text review will be conducted independently by two reviewers (KS and QRW). Any discrepancies will be resolved through discussion or by the inclusion of a third reviewer (DS).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A